Research ArticleMultiple Sclerosis

GDP-l-fucose synthase is a CD4+ T cell–specific autoantigen in DRB3*02:02 patients with multiple sclerosis

See allHide authors and affiliations

Science Translational Medicine  10 Oct 2018:
Vol. 10, Issue 462, eaat4301
DOI: 10.1126/scitranslmed.aat4301

Article Information

vol. 10 no. 462

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication February 26, 2018
  • Accepted for publication September 12, 2018

Author Information

  1. Raquel Planas1,
  2. Radleigh Santos2,
  3. Paula Tomas-Ojer1,
  4. Carolina Cruciani1,
  5. Andreas Lutterotti1,
  6. Wolfgang Faigle1,
  7. Nicole Schaeren-Wiemers3,
  8. Carmen Espejo4,
  9. Herena Eixarch4,
  10. Clemencia Pinilla2,
  11. Roland Martin1 and
  12. Mireia Sospedra1,*
  1. 1Neuroimmunology and MS Research (nims), Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zürich, Switzerland.
  2. 2Torrey Pines Institute for Molecular Studies, 11350 SW Village Parkway Port St. Lucie, FL 34987, USA.
  3. 3Department of Biomedicine, University Hospital Basel, Hebelstrasse 20, 4031 Basel, Switzerland.
  4. 4Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya, Vall d’Hebron Institut de Recerca, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  1. *Corresponding author. Email: mireia.sospedraramos{at}usz.ch

Altmetric

Article usage

Article usage: October 2018 to June 2019

AbstractFullPdf
Oct 20181547142391279
Nov 20181583180173
Dec 20188629384
Jan 20197329470
Feb 20194617742
Mar 20194464135
Apr 20194664633
May 20194523420
Jun 20193052926